De Leon Corporation     We’ve got time
Value Proposition: Death and Taxes• Forget taxes…• Death is the next big biotechnology  target!• This is not just disrupti...
Our Products• AgeRegress reverses the aging process.  Single dose.• Wide applications in human, veterinary,  and food scie...
Biotechnology Advances• First genomics, then proteomics, and  now….…..geriatromicsThe next frontier        yee haw
TheScience
Summary of Next 500 Science Slides• Very, very, very cool totally  incomprehensible technology that can  only be understoo...
AgeRegress• Initial product• Pilot studies already underway
Old Dog Model• Housebreaking side effect     Tricks/day 0        Tricks/day 2
Additional Product Line Extensions• Add to irrigation water for ever bearing  fruits and vegetables• Replace greenhouses!•...
AgeHalt• Chronic use• Recurrent revenue• No danger of patients getting too young  to pay for product
AgeHalt Use• Abrupt withdrawal symptoms:  – Women: use of blue hair rinses  – Men: Full Cleveland  – Trading in SUV for Ol...
Financial Requirements•   $20 million through pre-clinicals: 2007•   $40 million Phase 1 and 2: 2012•   $200 million to ma...
First round• A $1 million investment gets:       1% of the company and       unlimited product supply for personal      ...
Advisory Board Candidates• Mel Brooks• A Supreme Court Justice• A prominent member of Congress• Aging rock star
Our management team andboard of directors had over 400years of biotechnologyexperience until they becameoverinvolved in pr...
Invest NOW Ponce on this opportunity
DeLeon Corp (2001)
Upcoming SlideShare
Loading in...5
×

DeLeon Corp (2001)

806

Published on

Published in: Business, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
806
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

DeLeon Corp (2001)

  1. 1. De Leon Corporation We’ve got time
  2. 2. Value Proposition: Death and Taxes• Forget taxes…• Death is the next big biotechnology target!• This is not just disruptive technology… this is rude and recalcitrant technology!
  3. 3. Our Products• AgeRegress reverses the aging process. Single dose.• Wide applications in human, veterinary, and food science.• AgeHalt stops the aging process. Daily dosing.• Ideal chronic use profile
  4. 4. Biotechnology Advances• First genomics, then proteomics, and now….…..geriatromicsThe next frontier yee haw
  5. 5. TheScience
  6. 6. Summary of Next 500 Science Slides• Very, very, very cool totally incomprehensible technology that can only be understood by highly specialized PhD scientists and 25 year old venture capitalists recently ejected from business school who have undergraduate degrees in medieval history
  7. 7. AgeRegress• Initial product• Pilot studies already underway
  8. 8. Old Dog Model• Housebreaking side effect Tricks/day 0 Tricks/day 2
  9. 9. Additional Product Line Extensions• Add to irrigation water for ever bearing fruits and vegetables• Replace greenhouses!• Instant sushi: sprinkle yesterday’s fish with the product• Replace refrigeration!
  10. 10. AgeHalt• Chronic use• Recurrent revenue• No danger of patients getting too young to pay for product
  11. 11. AgeHalt Use• Abrupt withdrawal symptoms: – Women: use of blue hair rinses – Men: Full Cleveland – Trading in SUV for Oldsmobile
  12. 12. Financial Requirements• $20 million through pre-clinicals: 2007• $40 million Phase 1 and 2: 2012• $200 million to market: 2020• Cash flow positive in this century• Liquidity event: IPO as soon as the window opens
  13. 13. First round• A $1 million investment gets: 1% of the company and unlimited product supply for personal use
  14. 14. Advisory Board Candidates• Mel Brooks• A Supreme Court Justice• A prominent member of Congress• Aging rock star
  15. 15. Our management team andboard of directors had over 400years of biotechnologyexperience until they becameoverinvolved in productdevelopment
  16. 16. Invest NOW Ponce on this opportunity

×